首页 > 

fish protein

2025-01-24
fish protein
fish protein Ouster of NYPD Internal Affairs chief is latest in whirlwind shakeup of police brass

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in PG&E Co. ( NYSE:PCG – Free Report ) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 43,238 shares of the utilities provider’s stock, valued at approximately $855,000. Other large investors have also made changes to their positions in the company. Rothschild Investment LLC purchased a new stake in PG&E in the 2nd quarter worth $30,000. UMB Bank n.a. grew its position in shares of PG&E by 84.7% in the second quarter. UMB Bank n.a. now owns 2,204 shares of the utilities provider’s stock valued at $38,000 after purchasing an additional 1,011 shares during the period. Blue Trust Inc. increased its stake in shares of PG&E by 77.0% during the second quarter. Blue Trust Inc. now owns 2,361 shares of the utilities provider’s stock worth $40,000 after purchasing an additional 1,027 shares in the last quarter. Plato Investment Management Ltd acquired a new position in shares of PG&E during the 2nd quarter worth about $44,000. Finally, Massmutual Trust Co. FSB ADV lifted its stake in PG&E by 48.8% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 3,596 shares of the utilities provider’s stock valued at $63,000 after buying an additional 1,179 shares in the last quarter. 78.56% of the stock is owned by institutional investors and hedge funds. PG&E Price Performance PG&E stock opened at $21.37 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.99 and a debt-to-equity ratio of 2.02. The stock has a market cap of $55.89 billion, a P/E ratio of 16.70, a PEG ratio of 1.63 and a beta of 1.03. The company has a 50-day moving average price of $20.27 and a 200 day moving average price of $19.00. PG&E Co. has a 12-month low of $15.94 and a 12-month high of $21.51. PG&E Announces Dividend The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date was Monday, September 30th. PG&E’s dividend payout ratio is presently 3.13%. Analyst Ratings Changes Several equities research analysts have commented on PCG shares. Morgan Stanley boosted their price objective on PG&E from $19.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Wednesday, September 25th. Barclays increased their price objective on PG&E from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Jefferies Financial Group started coverage on shares of PG&E in a research note on Monday, October 14th. They set a “buy” rating and a $24.00 target price on the stock. UBS Group increased their target price on shares of PG&E from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Tuesday, September 3rd. Finally, Bank of America assumed coverage on shares of PG&E in a research report on Thursday, September 12th. They set a “buy” rating and a $24.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, PG&E presently has a consensus rating of “Moderate Buy” and an average target price of $22.80. View Our Latest Research Report on PG&E PG&E Profile ( Free Report ) PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, engages in the sale and delivery of electricity and natural gas to customers in northern and central California, the United States. It generates electricity using nuclear, hydroelectric, fossil fuel-fired, fuel cell, and photovoltaic sources. Featured Stories Want to see what other hedge funds are holding PCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PG&E Co. ( NYSE:PCG – Free Report ). Receive News & Ratings for PG&E Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PG&E and related companies with MarketBeat.com's FREE daily email newsletter .Since reaching a bear market bottom a little over two years ago, the bulls have been running the show on Wall Street. This year, the ageless Dow Jones Industrial Average ( ^DJI 0.97% ) , benchmark S&P 500 ( ^GSPC 0.35% ) , and growth stock-dependent Nasdaq Composite ( ^IXIC 0.16% ) have reached multiple all-time highs. The wind in Wall Street's sails has been a "team" effort, with the artificial intelligence (AI) revolution, stock-split euphoria, better-than-anticipated corporate operating results, a resurgence in share repurchase activity, and optimism following President-elect Donald Trump's victory all leading the charge. While this collection of catalysts might appear unstoppable on the surface, history offers a different lesson. The stock market had previously never done this throughout its storied history Since the height of the 2022 bear market, there have been a couple of predictive tools and correlative events that have foreshadowed trouble for the U.S. economy and/or Wall Street. The longest yield-curve inversion in history, a historically high S&P 500 Shiller price-to-earnings ratio , and the first meaningful drop in U.S. M2 money supply since the Great Depression have all previously served as warnings for Wall Street. But perhaps nothing screams "pay attention" to investors quite like the long-term valuation metric Berkshire Hathaway 's billionaire CEO Warren Buffett once touted. In a 2001 interview with Fortune magazine, Buffett lauded the market cap-to- gross domestic product (GDP) ratio as "probably the best single measure of where valuations stand at any given moment." Even though the aptly named Oracle of Omaha has backed away from solely relying on this valuation tool, it's commonly referred to as the "Buffett Indicator" on Wall Street . The Buffett Indicator takes the collective market value of a country's publicly traded stocks and divides that figure into its GDP. The lower the ratio, the cheaper stocks are perceived to be. Conversely, when the ratio is high, it suggests stocks are historically pricey compared to the underlying growth rate of the economy. The most-effective way to measure the value of publicly traded stocks in the U.S. is with the Wilshire 5000 Index . Each "point" higher or lower in the Wilshire 5000 Index represents a little over $1 billion gained or lost in the aggregate market value of U.S. stocks. Based on 55 years' worth of Wilshire 5000-to-GDP ratio data, which has been aggregated by Longtermtrends.net, the average reading of this "Buffett Indicator" is about 85%. In other words, the cumulative value of U.S. stocks represents about 85% the value of U.S. GDP, on average, dating back to the start of 1970. But after close to three decades below this mean (1970 through most of 1998), the Wilshire 5000-to-GDP ratio has spent almost the entire last quarter of a century at a premium to this average. In some respects, a more aggressive valuation is warranted. The advent of the internet positively changed the growth trajectory for corporate America. Likewise, it democratized access to information, which when coupled with historically low interest rates encouraged everyday investors to take more risk. However, the stock market just crossed a threshold that's never been reached with this widely followed ratio. In October, the Buffett Indicator surpassed 200% for the first time ever , and it peaked at almost 206% on Nov. 10. This is well above its 55-year average and is considerably higher than the respective peaks of 144% during the dot-com bubble and 107% prior to the financial crisis taking shape. Although the Wilshire 5000-to-GDP ratio isn't a timing tool -- i.e., it's not going to tell investors when to expect big directional moves in the Dow Jones, S&P 500, and Nasdaq Composite -- it does have an exceptionally strong track record of portending downside in stocks when valuations become historically extended. A sizable jump from in the Buffett Indicator from 60% to 144% from the end of 1994 until the dot-com bubble bust in March 2000 gave way to a near-halving in the S&P 500 and considerably larger losses in the tech-heavy Nasdaq. Another noteworthy increase occurred between the dot-com bubble bottom at 67% in October 2002 and the aforementioned 107% Wilshire 5000-to-GDP ratio that was reached in 2007 prior to the financial crisis taking shape. The benchmark S&P 500 lost 57% during the Great Recession. Since bottoming out at 112% on March 22, 2020 (during the height of the COVID-19 crash), the Wilshire 5000-to-GDP ratio has soared to the aforementioned 206%. If history tells us anything, it's that investors should eventually (key word!) expect a steep and/or sharp decline lower in all three major stock indexes. Time has a way of paying off handsomely for patient investors While warning signs are readily apparent for a historically pricey stock market, perspective and time paint an entirely different picture. For example, history tells us that recessions are a normal and inevitable part of the economic cycle. No matter how much we might dislike the adverse impact on employment and wages that accompanies recessions, they're a common occurrence over the long run. However, the ability for workers/investors to take a step back and widen their lens presents a different story. Although recessions are normal, they've resolved quickly since the end of World War II in 1945 . Out of the 12 downturns in the U.S. economy over the last 79 years, nine ended in less than a year, while the remaining three failed to surpass 18 months in length. The overwhelming majority of economic expansions have endured longer than the lengthiest recession in the post-World War II era. What the above comparison demonstrates is that economic cycles aren't linear. In other words, the U.S. economy spends a disproportionate amount of time in the sun, rather than under storm clouds. This is fantastic news for America's most-influential businesses because this non-linearity extends to the stock market. The data set you'll note above was published on social media platform X by the researchers at Bespoke Investment Group in June 2023, shortly after the S&P 500 was confirmed to have entered a new bull market . What this data set shows is the calculated calendar-day length of every bear and bull market for the S&P 500 dating back to the start of the Great Depression in September 1929. The average S&P 500 bear market, which sees the index decline by at least 20% in value from a recent high, was calculated to last 286 calendar days, or roughly 9.5 months . On the other end of the spectrum, the typical bull market has stuck around for 1,011 calendar days, which is approximately 3.5 times as long. What's even more telling is that 14 out of 27 S&P 500 bull markets (including the current bull market) have endured longer than the lengthiest S&P 500 bear market on record (630 calendar days). Regardless of how worrisome predictive metrics may appear over short time frames, they can't hold a candle to investors' greatest ally: time.

Americans Need $5.3 Million Net Worth to Be Considered Financially Successful: Survey

Shiba Inu And Dogecoin Struggle To Match PropiChain’s Predicted 30,000% Growth Potential

Mumbai: Heart surgeries at BMC-run BYL Nair Hospital and Medical College in Mumbai Central have been suspended for the past ten days due to a halt in the supply of essential surgical materials. The issue arose after vendors stopped delivering supplies because of unpaid bills. Families of patients admitted to the hospital are now worried that delays caused by this issue could have dire consequences for their loved ones. The Cardiovascular and Thoracic Surgery (CVTS) department at Nair Hospital is well-known for treating heart-related ailments and performing life-saving surgeries. Patients with heart attacks often require procedures like angioplasty, bypass surgery, valve replacement, or thoracic aortic aneurysm repair. However, surgeries have come to a standstill over the past several days. "We have been streamlining the process, and the clearing of payments started this week. However, the vendors are insisting that they will not resume supplies until they receive a substantial amount," said a BMC official from Nair Hospital. The official added that in the CVTS department, only open-heart surgeries and valve-related surgeries are on hold, and they are trying their best to resume services at the earliest. According to hospital sources, the CVTS department informed the hospital dean in a letter dated December 4 that vendors had stopped supplying essential items like oxygenators due to unpaid bills. Without these materials, no heart surgeries can be performed. The department requested permission to refer patients to other BMC hospitals. An employee at the hospital criticized the situation, saying, “Poor patients come to BMC hospitals hoping for solutions to their problems. It’s shameful that such a large hospital has to shut down its operations due to unpaid bills. If any untoward incident occurs with a patient, the BMC administration will be held accountable.” Earlier in March, the department had to stop surgeries due to pending bills. At the time, the dean ordered CVTS surgeries to be referred to other hospitals. "This has been a recurring problem since last December. It was first flagged to the dean last year when vendors expressed reluctance to supply surgery-related materials due to a backlog of pending bills for various surgeries conducted under government schemes," said a senior official from Nair Hospital. Another official noted that over the past year, delays in clearing vendor bills at Nair Hospital have affected the functioning of not just the CVTS department but also others, such as ophthalmology, cardiology, and orthopaedics. "We are repeatedly seeing delays in payments to food vendors and laundry supply vendors as well. The payment of vendors is becoming a serious issue that higher authorities need to resolve at the earliest," said a doctor.

Burmans' Religare open offer to acquire additional stake gets Sebi nodBirdlkportfolio/iStock via Getty Images Innoviz's ( NASDAQ: INVZ ) share price has been below $1 for almost six months since I wrote about it in May, but it just breached this threshold with news about Mobileye ( MBLY ) using its sensors in the Analyst’s Disclosure: I/we have a beneficial long position in the shares of OUST either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Previous: fish meme
Next: fish stock